Ignite Creation Date:
2025-12-24 @ 5:08 PM
Ignite Modification Date:
2025-12-28 @ 4:13 PM
Study NCT ID:
NCT00004050
Status:
TERMINATED
Last Update Posted:
2014-07-29
First Post:
1999-12-10
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Leuvectin Followed By Surgery in Treating Patients With Stage II or Stage III Prostate Cancer
Sponsor:
Vical
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
1999-06
Start Date Type:
None
Primary Completion Date:
2003-04
Primary Completion Date Type:
ACTUAL
Completion Date:
2003-04
Completion Date Type:
ACTUAL
First Submit Date:
1999-12-10
First Submit QC Date:
None
Study First Post Date:
2003-10-29
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2014-07-25
Last Update Post Date:
2014-07-29
Last Update Post Date Type:
ESTIMATED